Application

18523746 · Compounds and Methods for Reducing LRRK2 Expression

Filed 2023-11-29 · Granted · Patent 12241067 (2025-03-04) The official file ↗The patent and its PDF ↗ · Art unit 1637 · Examiner Ekaterina Poliakova-Georgan Typical · CPC A61P 25/16 · Ionis Pharmaceuticals, Inc. · Ionis Pharmaceuticals, Inc.

Office actions

first was Notice of allowance

RCEs

no appeal

To first action

8.8 mo

to disposition 15.1 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.